A phase I safety and feasibility trial of subcutaneous hirudin (lepirudin) alone and in combination with chemotherapy in metastatic breast cancer patients.
Publication
, Conference
Larned, ZL; Daly, L; Marcom, PK; Ortel, TL; O'Shea, S; Greenberg, C; Blackwell, K
Published in: BLOOD
November 16, 2003
Duke Scholars
Published In
BLOOD
ISSN
0006-4971
Publication Date
November 16, 2003
Volume
102
Issue
11
Start / End Page
126B / 126B
Location
SAN DIEGO, CALIFORNIA
Publisher
AMER SOC HEMATOLOGY
Conference Name
45th Annual Meeting of the American-Society-of-Hematology
Related Subject Headings
- Immunology
- 3213 Paediatrics
- 3201 Cardiovascular medicine and haematology
- 3101 Biochemistry and cell biology
- 1114 Paediatrics and Reproductive Medicine
- 1103 Clinical Sciences
- 1102 Cardiorespiratory Medicine and Haematology
Citation
APA
Chicago
ICMJE
MLA
NLM
Larned, Z. L., Daly, L., Marcom, P. K., Ortel, T. L., O’Shea, S., Greenberg, C., & Blackwell, K. (2003). A phase I safety and feasibility trial of subcutaneous hirudin (lepirudin) alone and in combination with chemotherapy in metastatic breast cancer patients. In BLOOD (Vol. 102, pp. 126B-126B). SAN DIEGO, CALIFORNIA: AMER SOC HEMATOLOGY.
Larned, Z. L., L. Daly, P. K. Marcom, T. L. Ortel, S. O’Shea, C. Greenberg, and K. Blackwell. “A phase I safety and feasibility trial of subcutaneous hirudin (lepirudin) alone and in combination with chemotherapy in metastatic breast cancer patients.” In BLOOD, 102:126B-126B. AMER SOC HEMATOLOGY, 2003.
Larned ZL, Daly L, Marcom PK, Ortel TL, O’Shea S, Greenberg C, et al. A phase I safety and feasibility trial of subcutaneous hirudin (lepirudin) alone and in combination with chemotherapy in metastatic breast cancer patients. In: BLOOD. AMER SOC HEMATOLOGY; 2003. p. 126B-126B.
Larned, Z. L., et al. “A phase I safety and feasibility trial of subcutaneous hirudin (lepirudin) alone and in combination with chemotherapy in metastatic breast cancer patients.” BLOOD, vol. 102, no. 11, AMER SOC HEMATOLOGY, 2003, pp. 126B-126B.
Larned ZL, Daly L, Marcom PK, Ortel TL, O’Shea S, Greenberg C, Blackwell K. A phase I safety and feasibility trial of subcutaneous hirudin (lepirudin) alone and in combination with chemotherapy in metastatic breast cancer patients. BLOOD. AMER SOC HEMATOLOGY; 2003. p. 126B-126B.
Published In
BLOOD
ISSN
0006-4971
Publication Date
November 16, 2003
Volume
102
Issue
11
Start / End Page
126B / 126B
Location
SAN DIEGO, CALIFORNIA
Publisher
AMER SOC HEMATOLOGY
Conference Name
45th Annual Meeting of the American-Society-of-Hematology
Related Subject Headings
- Immunology
- 3213 Paediatrics
- 3201 Cardiovascular medicine and haematology
- 3101 Biochemistry and cell biology
- 1114 Paediatrics and Reproductive Medicine
- 1103 Clinical Sciences
- 1102 Cardiorespiratory Medicine and Haematology